Business Context and Reporting Period
This Form 6-K filing by Lichen International Ltd covers the month ended March 2025. The report addresses a critical regulatory matter regarding the Company's continued listing status on The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and listing compliance.
Material Changes and Listing Status
- Initial Deficiency: On January 23, 2025, the Company received a deficiency letter from Nasdaq for failing to meet the minimum bid price requirement (Rule 5450(a)(1)).
- Delisting Threat: On February 12, 2025, Nasdaq notified the Company that its closing bid price was $0.10 or less for ten consecutive trading days, triggering the Low Priced Stocks Rule and threatening suspension and delisting.
- Appeal Filed: The Company requested a hearing before the Hearings Panel on February 19, 2025, to appeal the delisting determination.
- Compliance Regained: On March 19, 2025, Nasdaq confirmed the Company maintained a closing bid price of at least $1.00 per share for 10 consecutive business days.
- Resolution: The scheduled hearing for March 25, 2025, was canceled, and the Company's securities will continue to be listed and traded on Nasdaq.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of financial risks. The primary risk addressed was the potential delisting from Nasdaq, which has been resolved as of the filing date.
Investor Verification Checklist
- Verify the current trading price of Lichen International Ltd shares to ensure continued compliance with the $1.00 minimum bid price requirement.
- Confirm the cancellation of the March 25, 2025, hearing via Nasdaq official announcements.
- Review subsequent filings for any new deficiency notices or changes in listing status.